New hope for tough pancreatic cancers: chemo plus precision radiation
NCT ID NCT03991962
First seen Nov 10, 2025 · Last updated May 21, 2026 · Updated 34 times
Summary
This study tested a two-step treatment for people with pancreatic cancer that is either borderline removable or locally advanced but hasn't spread. First, patients received a strong chemotherapy combination called modified FOLFIRINOX, followed by precise, high-dose radiation (SBRT). The goal was to see if this approach could delay cancer growth better than older treatments. The study enrolled 28 adults who had not received prior cancer therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.